News

Envisagenics, a developer of novel RNA splicing therapeutics, has secured an undisclosed amount of Series A funding.

Japanese barbecue sauce creator Bachan's has raised an undisclosed amount of funding.

New York- and Israel-based Avo, a residential and office delivery platform, has raised $45 million in Series B funding.

Totango, a customer success platform, has raised $100 million in Series D funding.

TailorMed, a patient financial navigation technology company, has raised its overall funding tally to $25 million.

Expansion Therapeutics, Inc., a developer of oral medicines for severe RNA-mediated diseases, has secured $80 million in Series B financing.

Pattern Pharma, a Toronto-based immunotherapy company focused on combating cancer and infectious disease, has collected C$5 million in financing.

Vital, a provider of AI-powered software for improving patient experience, has secured $15 million in Series A funding.

Vancouver-based agricultural technology startup Semios has secured $100 million in financing led by Morningside Group.

The early-stage firm was co-founded by Austin Clements, formerly a principal at TenOneTen Ventures.